PUBLISHER: Value Market Research | PRODUCT CODE: 1274333
PUBLISHER: Value Market Research | PRODUCT CODE: 1274333
The global demand for Pharmaceutical Dissolution Testing Services Market is presumed to reach the market size of nearly USD 1574.95 MN by 2030 from USD 677.53 MN in 2022 with a CAGR of 11.12% under the study period 2023 - 2030.
Pharmaceutical dissolution testing refers to the test used in the pharmaceutical industry to assess the physical changes in an active pharmaceutical drug. It assists in determining the bioavailability and therapeutic effectiveness of all solid and semi-solid oral dosages. Pharmaceutical products are developed on the basis of these drug dissolution tests. It is used as a quality control tool for monitoring the drug released from the substance. Drug dissolution test helps in determining the pace with which the medications go into different areas of the body and the time they take to dissolve.
The pharmaceutical dissolution testing services market is anticipated to scale up due to the development of various drugs for different chronic conditions. The rise in the cases of Type 2 diabetes is contributing to the growth of the pharmaceutical dissolution testing service market. Moreover, the increasing number of clinical studies and drugs approval is surging the demand for this market. Growth in the number of innovative drugs entering the preclinical stage of development is propelling the demand for this market. Furthermore, the rise in pharmaceutical research efforts coupled with large corporations' rising interest and increasing spending for research and development in this area is expected to boost the growth of this market in the upcoming years.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of pharmaceutical dissolution testing services. The growth and trends of pharmaceutical dissolution testing services industry provide a holistic approach to this study.
This section of the pharmaceutical dissolution testing services market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the Pharmaceutical Dissolution Testing Services market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the pharmaceutical dissolution testing services market include Intertek Group Plc., Avivia BV, Almac Group, Agilent Technologies Inc., Catalent Inc., Thermofisher Scientific Inc., Cambrex Corp, Charles River Laboratories, Boston Analytical, Pace Analytical Life Sciences, Sotax, Amri, SGS SA. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.